Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/41710
Title: The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review.
Authors: 
Keywords: 
Mesh: 
Issue Date: 2017
Citation: Oncologist.2017 03;(22)3:272-285
Abstract: Neuroendocrine tumors (NETs) are a heterogeneous group of tumors, with >50% of cases involving the gastrointestinal system or pancreas. Somatostatin analogs (SSAs) are used for treating NET-related secretory syndromes and, more recently, for their antiproliferative effects. We conducted a systematic review of published literature on the antiproliferative efficacy and safety of the SSA lanreotide Autogel in the management of NETs to gain a fuller understanding of the evidence and identify future areas of research.
PMID: 28220021
URI: https://hdl.handle.net/20.500.12530/41710
Rights: openAccess
Appears in Collections:Hospitales > H. U. 12 de Octubre > Artículos

Files in This Item:
File Description SizeFormat 
PMC5344642.pdf392.72 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.